JP4347914B2 - 慢性気管支炎の治療方法 - Google Patents

慢性気管支炎の治療方法 Download PDF

Info

Publication number
JP4347914B2
JP4347914B2 JP54592598A JP54592598A JP4347914B2 JP 4347914 B2 JP4347914 B2 JP 4347914B2 JP 54592598 A JP54592598 A JP 54592598A JP 54592598 A JP54592598 A JP 54592598A JP 4347914 B2 JP4347914 B2 JP 4347914B2
Authority
JP
Japan
Prior art keywords
indole
methyl
oxy
indol
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP54592598A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001524962A5 (https=
JP2001524962A (ja
Inventor
マシアス，ウィリアム・エル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of JP2001524962A publication Critical patent/JP2001524962A/ja
Publication of JP2001524962A5 publication Critical patent/JP2001524962A5/ja
Application granted granted Critical
Publication of JP4347914B2 publication Critical patent/JP4347914B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
JP54592598A 1997-03-26 1998-03-24 慢性気管支炎の治療方法 Expired - Fee Related JP4347914B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4210197P 1997-03-26 1997-03-26
US60/042,101 1997-03-26
PCT/US1998/005791 WO1998042343A1 (en) 1997-03-26 1998-03-24 Method for treatment of chronic bronchitis

Publications (3)

Publication Number Publication Date
JP2001524962A JP2001524962A (ja) 2001-12-04
JP2001524962A5 JP2001524962A5 (https=) 2005-11-10
JP4347914B2 true JP4347914B2 (ja) 2009-10-21

Family

ID=21920055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54592598A Expired - Fee Related JP4347914B2 (ja) 1997-03-26 1998-03-24 慢性気管支炎の治療方法

Country Status (8)

Country Link
US (1) US5972988A (https=)
EP (1) EP1007046A4 (https=)
JP (1) JP4347914B2 (https=)
AU (1) AU6771798A (https=)
CA (1) CA2284757A1 (https=)
MY (1) MY114942A (https=)
WO (1) WO1998042343A1 (https=)
ZA (1) ZA982454B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2309135A1 (en) * 1997-10-27 1999-05-06 Michael Lyle Denney N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors
ES2241178T3 (es) 1997-10-27 2005-10-16 Eli Lilly And Company Profarmacos de ester de morlino-n-etilo de inhibidores indolicos de spla 2.
CZ302588B6 (cs) * 1998-04-02 2011-07-27 Ziopharm Oncology, Inc. Použití N-substituovaného indol-3-glyoxylamidu pro výrobu léciva
US6576654B1 (en) * 1998-09-23 2003-06-10 Eli Lilly And Company Method for the treatment of cystic fibrosis
US6274578B1 (en) 1999-04-20 2001-08-14 Eli Lilly And Company sPLA2 inhibitor ester
US6140327A (en) * 1999-05-12 2000-10-31 Eli Lilly And Company Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
AU2252201A (en) * 1999-12-16 2001-06-25 Eli Lilly And Company Carbon monoxide-based synthesis of spla2 inhibitors
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
WO2001081306A2 (en) * 2000-04-19 2001-11-01 Eli Lilly And Company Azide cyclization-based synthesis and intermediates for spla2 inhibitors
MXPA05004121A (es) * 2002-10-18 2006-02-17 Molichem Medicines Inc Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
JP2006518738A (ja) * 2003-02-12 2006-08-17 トランス　テック　ファーマ，インコーポレイテッド 治療薬としての置換アゾール誘導体
CA2565545A1 (en) * 2004-05-06 2005-12-08 Molichem Medicines, Inc. Treatment of ocular diseases and disorders using lantibiotic compositions
US7326683B2 (en) * 2004-05-06 2008-02-05 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
US20150338425A1 (en) * 2011-11-14 2015-11-26 The Brigham And Women's Hospital, Inc. Treatment and prognosis of lymphangioleiomyomatosis
WO2014137978A1 (en) 2013-03-04 2014-09-12 The Brigham And Women's Hospital, Inc. Treatment of lymphangioleiomyomatosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9501404A (pt) * 1994-04-01 1996-03-05 Lilly Co Eli 1H-indol-3 glioxilamida e formulação farmacèutica

Also Published As

Publication number Publication date
AU6771798A (en) 1998-10-20
MY114942A (en) 2003-02-28
EP1007046A4 (en) 2000-11-29
CA2284757A1 (en) 1998-10-01
US5972988A (en) 1999-10-26
ZA982454B (en) 1999-09-23
EP1007046A1 (en) 2000-06-14
WO1998042343A1 (en) 1998-10-01
JP2001524962A (ja) 2001-12-04

Similar Documents

Publication Publication Date Title
JP4347914B2 (ja) 慢性気管支炎の治療方法
JPH10503208A (ja) １Ｈ−インドール−１−官能性ｓＰＬＡ▲下２▼インヒビター
JPH08511032A (ja) ５−アリールインドール誘導体
US5106847A (en) Excitatory amino acid antagonists, compositions and use
US6610728B2 (en) Method for treatment of non-rheumatoid arthritis
JPH08505375A (ja) 置換基をもつトリオール類
SK8752002A3 (en) Substituted N-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect
JPWO1999043652A1 (ja) インドール誘導体および当該誘導体を含有する医薬品組成物
CA2152401C (fr) Association synergisante ayant un effet antagoniste des recepteurs nk1 et nk2
JP3006881B2 (ja) ３―インドリルチオアセテート誘導体類
WO1999024033A1 (en) Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
WO2005056012A1 (en) Indole derivatives for the treatment of bone diseases
US6140324A (en) Use of a tachykinin antagonist and a muscarinic antagonist and/or an antihistamine to treat motion sickness
JP2001517707A (ja) 嚢胞性繊維症の処置方法
US6436983B1 (en) Treatment for alzheimer's disease
US6214855B1 (en) Method for the treatment of stroke using N-heterocyclic glyoxlyamide compounds
JPH0688987B2 (ja) １、３―チアゾリジンのβ―カルボニルカルボキシアミド
EP0929521A1 (en) Nmda (n-methyl-d-aspartate) antagonists
US6340699B1 (en) SPLA2 inhibitor compounds for treatment of disease
US6576654B1 (en) Method for the treatment of cystic fibrosis
AU2001272915A1 (en) Method for treating sepsis
US20040110825A1 (en) Method for treating sepsis
JP2002504893A (ja) Ｎ−ヘテロ環グリオキサミド化合物を用いた脳卒中の治療方法
US20030149000A1 (en) Method for the treatment of disorders associated with apoptosis using N-heterocyclic glyoxylamide compounds
JP2003246732A (ja) １，２−エタンジオール誘導体またはその塩を含有する神経断裂治療剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050323

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050323

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20061219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090319

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090707

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090717

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120724

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120724

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130724

Year of fee payment: 4

LAPS Cancellation because of no payment of annual fees